http://drugdiscovery.pharmaceutical-business-review.com/news/bafna_pharm...

For the treatment of hypertension

Bafna Pharmaceuticals has received approval from Sri Lankan authorities for the launch of Olmesartan Medoxomil, anti-hypertension drug. The drug will be launched as Olmebaf, and will initiate marketing in Sri Lanka next year.